Format

Send to

Choose Destination
Clin Immunol. 2012 Sep;144(3):250-68. doi: 10.1016/j.clim.2012.06.003. Epub 2012 Jun 20.

On the armament and appearances of human myeloid-derived suppressor cells.

Author information

1
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden. Isabel.Poschke@ki.se

Abstract

Myeloid-derived suppressor cells (MDSC) have frequently been observed in patients with cancer. This heterogeneous population of myeloid cells can exert potent suppression of lymphocyte function and thereby poses a significant hurdle to natural or therapeutically induced anti-tumor immunity. On the other hand, the natural function of MDSC is not yet well understood and their role in infection, inflammation and autoimmune disease is still puzzling. Understanding MDSC biology will provide the tools necessary for therapeutic targeting of this population, but also permit exploitation of their strong tolerogenic function in the treatment of inflammatory conditions and the prevention of graft rejection.

PMID:
22858650
DOI:
10.1016/j.clim.2012.06.003
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center